ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1179 • 2016 ACR/ARHP Annual Meeting

    The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome

    Nuria Lozano-Rivas1, Carlos Marras Fernandez-Cid2, Francisco Jose Pastor Perez3, Pedro Flores-Blanco4, Miriam Gomez-Molina4, Alberto Bermudez5, Luis Francisco Linares2, Javier Martinez Ferrin2, Francisco Andrés Martinez-Angosto1, Pablo Mesa del Castillo2 and Sergio Manzano-Fernandez4, 1Rheumatology, Hospital Virgen de la Arrixaca, murcia, Spain, 2Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain, 3Cardiology, Hospital Virgen de la Arrixaca, Murcia, Spain, 4Cardiology, Hospital Virgen de la Arrixaca, murcia, Spain, 5Hospital Virgen de la Arrixaca, Molina de Segura (Mu, Spain

    Background/Purpose: Patients with autoimmune diseases (AID) have a high burden of cardiovascular disease leading to premature morbidity and mortality. But it is unclear if it…
  • Abstract Number: 1180 • 2016 ACR/ARHP Annual Meeting

    Class V Lupus Nephritis Results in Significant Numbers of End Stage Renal Disease and Death in a Population-Based Registry

    Jennifer Brandt1, Cristina Drenkard2, Jason Cobb3, Gaobin Bao4 and S. Sam Lim4, 1Department of Rheumatology, Emory University School of Medicine, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA, 3Department of Nephrology, Emory University School of Medicine, Atlanta, GA, 4Medicine, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Although the diagnosis of pure class V lupus nephritis (LN) is generally thought to portend a favorable prognosis, outcomes on a population-level are not…
  • Abstract Number: 1181 • 2016 ACR/ARHP Annual Meeting

    Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis

    Brian Le1,2, Jennifer Waller3, Reshmitha Radhakrishnan4, Sun Jung Oh4, Monique Bethel2,5, Christopher Rice4 and Laura Carbone2,6, 1Department of Internal Medicine, Augusta University, Augusta, GA, 2Specialty Care, Charlie Norwood VA Medical Center, Augusta, GA, 3Biostatistics, Augusta University, Augusta, GA, 4School of Medicine, Augusta University, Augusta, GA, 51120 15th Street, BI 5070, Augusta University, Augusta, GA, 6Rheumatology, Augusta University, Augusta, GA

    Background/Purpose:  Osteoporosis and osteoporotic fractures are significant comorbidities in patients with systemic lupus erythematosus (SLE). Hip fractures are being increasingly recognized as a complication of…
  • Abstract Number: 1182 • 2016 ACR/ARHP Annual Meeting

    Opiod Use and Death in Chronic Pain Patients with Systemic Lupus Erythematosis

    Romy Cabacungan1, Clifford Qualls2, Wilmer Sibbitt Jr.1, Timothy Moore1, Luis Salayandia1, Roderick Fields3, Suzanne Emil1, Monthida Fangtham1, Konstantin Konstantinov4, Tej Bhavsar1 and Arthur Bankhurst5, 1Rheumatology, University of New Mexico, Albuquerque, NM, 2Biostatistics, UNM, Albuquerque, NM, 3Internal Medicine/ Rheumatology, University of New Mexico School of Medicine, Albuquerque, NM, 41 University Of New Mexico, University of New Mexico, Albuquerque, NM, 5Rheumatology, University of NM Medical Center, Albuquerque, NM

    Background/Purpose:   Chronic pain is one of the most common symptoms reported in patients with SLE. Treating pain in these individuals can be complex and…
  • Abstract Number: 1183 • 2016 ACR/ARHP Annual Meeting

    Lack of Awareness of Sexual Health in Rheumatology. High Prevalence of Sexual Dysfunction Among Women with Rheumatic Diseases

    Alejandro Garza-Alpirez1, David Vega-Morales2, Wendy Orzua-de la Fuente1, Ana Arana-Guajardo3, Diana Flores-Alvarado4, Jorge Esquivel-Valerio5, Mario Alberto Garza-Elizondo5 and Lorena Pérez-Barbosa6, 1Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Universidad Autónoma de Nuevo Léon, Monterrey, Mexico, 3Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 4Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 5Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 6Hospital Universitario, Monterrey, Mexico

    Background/Purpose: Rheumatic diseases comprise a diverse group of about 150 degenerative, autoimmune and autoinflammatory diseases. Sexual dysfunction affects about 70% of patients with rheumatic diseases…
  • Abstract Number: 1184 • 2016 ACR/ARHP Annual Meeting

    Projected 2015 Prevalence of Physician-Diagnosed Primary SjöGren’s Syndrome Based on 1976-2005 Annual Incidence Rates in a Well-Defined U.S. Population

    Divi Cornec1, Eric L. Matteson2 and Cynthia S. Crowson3, 1Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 2Rheumatology, Mayo Clinic, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: Estimates of prevalence of primary Sjögren’s syndrome (pSS) are conflicting, ranging from 1 to more than 8 cases per 10,000 according to different population-based…
  • Abstract Number: 1185 • 2016 ACR/ARHP Annual Meeting

    Increased Risk of Osteoporotic Fractures in Patients with Primary SjöGren Syndrome: A Nationwide Population-Based Study in Taiwan

    Yen Po Tsao1,2, Yu Sheng Chang3, Chien Chih Lai1,2, Wei Sheng Chen1,2 and Chang Youh Tsai4,5, 1National Yang-Ming University, Taipei, Taiwan, 2Department of medicine, division of allergy, immunology, rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan, 3Taipei Medical University, New Taipei City, Taiwan, 4Taipei Veterans General Hospital, Taipei, Taiwan, 5Department of medicine, division of allergy, immunology, rheumatology, National Yang-Ming University, Taipei, Taiwan

    Background/Purpose: ö is an autoimmune disease involved multiple organs, including exocrine glands, lungs, and bone marrow. Patients with pSjS are vulnerable to fatigue and pain…
  • Abstract Number: 1186 • 2016 ACR/ARHP Annual Meeting

    The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients

    Cristián Vera-Kellet Sr., Pablo del Barrio-Díaz Sr., Jorge Manríquez-Moreno Sr. and Carlos Reyes-Vivanco Sr., Dermatology, Pontificia Universidad Católica de Chile, Santiago, Chile

    Background/Purpose: There are few studies comparing oral manifestations in patients with Cutaneous Lupus (CL), Systemic Lupus Erythematosus (SLE) and Dermatomyositis (DM). Our objective was to…
  • Abstract Number: 1187 • 2016 ACR/ARHP Annual Meeting

    Ultraviolet Radiation Exposures Are Associated with Dermatomyositis in a National Myositis Registry

    Christine G. Parks1, Jesse Wilkerson2, Kathryn M. Rose2, Abdullah Faiq3, Payam Noroozi Farhadi3, Craig S. Long4, Nastaran Bayat3, Hermine I. Brunner5, Bob Goldberg6, John McGrath2, Frederick W. Miller3 and Lisa G. Rider3, 1Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Durham, NC, 2Social and Scientific Systems, Inc., Durham, NC, 3Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, MD, 4NOAA/National Weather Service, National Centers for Environmental Prediction Climate Prediction Center, College Park, MD, 5Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6The Myositis Association, Alexandria, VA

    Background/Purpose:  Previous studies suggest exposure to ultraviolet (UV) radiation may be a risk factor for dermatomyositis (DM) and autoantibody phenotypes, based on differences in prevalence…
  • Abstract Number: 1188 • 2016 ACR/ARHP Annual Meeting

    Major Comorbidities of Idiopathic Inflammatory Myositis: A Population-Based Study Using 10 Years of Follow up from the National Health Insurance in Korea

    Jeong Seok Lee1, Min Jung Kim2, Hee Young Lee3, So Yeon Ahn4, Yeong Wook Song5, Eun Bong Lee6, Eun Young Lee7, Yun Jong Lee8 and Eun Ha Kang9, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 2Division of Rheumatology, Departmenf of Internal Medicine, Seoul National University Hospital, Seoul, Korea, The Republic of, 3Center for Preventive Medicine and Public health, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, 4Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, 5Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea, Seoul, Korea, The Republic of, 6Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea, Seoul, Korea, The Republic of, 7Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, South Korea, 8Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, 9Division of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of

    Major comorbidities of idiopathic inflammatory myositis: A population-based study using 10 years of follow up from the national health insurance in KoreaJeong Seok Lee1, Min…
  • Abstract Number: 1189 • 2016 ACR/ARHP Annual Meeting

    Inpatient Trends for Adults with Scleroderma in the United States: A 20 Year Analysis

    Noopur Goel1, Ishan Lalani2 and Iram Moledina3, 1Internal Medicine, Monmouth Medical Center, monmouth beach, NJ, 2Internal Medicine, Monmouth Medical Center, Ocean, NJ, 3Gujarat Adani Institute of Medical Sciences, New Haven, CT

  • Abstract Number: 1190 • 2016 ACR/ARHP Annual Meeting

    Incidence and Prevalence of Polymyalgia Rheumatic and Giant Cell Arteritis: A 15-Year Study in a Health Care Management Organization

    Jose Maximiliano Martinez P1, Florencia Beatriz Mollerach2, Facundo Vergara2, Ignacio Javier Gandino2, Marina Scolnik3, Luis J. Catoggio4, Javier Rosa2 and Enrique R. Soriano2, 1Rheumatology, Internal Medicine Service, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 2Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 3Rheumatology Section, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 4Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Argentina., Buenos Aires, Argentina

    Background/Purpose: There is scarce information on the epidemiology of polymyalgia rheumatic (PMR) and giant cell arteritis (GCA) in Latin America. To estimate incidence and prevalence rates of…
  • Abstract Number: 1191 • 2016 ACR/ARHP Annual Meeting

    Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk

    Max Yates1, Shabina Hayat2, Robert N. Luben3, Roshan Welikala4, Alicja Rudnicka5, Christopher Owen5, Sarah Barman4, Eoin O'Sullivan6, Sarah Mackie7, Richard Watts1, Paul Foster8, Kay-Tee Khaw3, Nick Wareham3 and Alex J Macgregor9, 1Norwich Medical School, University of East Anglia, Norwich, United Kingdom, 2Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom, 3Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, 4Faculty of Science, Engineering and Computing, University of Kingston, London, United Kingdom, 5Population Health Research Institute, St George's University of London, London, United Kingdom, 6Ophthalmology, Kings College Hospital, London, United Kingdom, 7NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, University of Leeds, Leeds, United Kingdom, 8Division of Epidemiology and Genetics, University College London, London, United Kingdom, 9Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom

    Background/Purpose:  Increasing evidence suggests that characteristic changes in retinal vessel morphometry are biomarkers for vascular health. Polymyalgia Rheumatica (PMR) has been associated with increased risk…
  • Abstract Number: 1192 • 2016 ACR/ARHP Annual Meeting

    Mortality and Survival of Patients Diagnosed with GCA in Bergen (Western Norway) 1972-2012

    Lene K Brekke1, Andreas P Diamantopoulos1, Bjørg-Tilde Fevang2,3, Jörg Aβmus4 and Clara G Gjesdal3,5, 1Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway, 2Dept. of Rheumatology, Haukeland University Hospital, Bergen, Norway, 3Department of Clinical Science, University of Bergen, Bergen, Norway, 4Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway, 5Department of Rheumatology, Haukeland University Hospital, Bergen, Norway

    Background/Purpose: Giant cell arteritis (GCA) is the most common systemic vasculitis in people ³ 50 years of age and the disease is associated with potentially…
  • Abstract Number: 1193 • 2016 ACR/ARHP Annual Meeting

    Mortality Rate According to Cause in Patients with Hemophagocytic Lymphohistiocytosis: A Meta-Analysis

    Khushboo Sheth1,2, Chia-Ling Kuo3, Dhruv Modi4 and Christopher Scola5, 1Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, 2Rheumatology, Stanford University, Palo Alto, CA, 3Department of Community Medicine and Health Care, University of Connecticut, Farmington, CT, 4Internal Medicine, Jamaica Hospital and Medical Center, New York, NY, 5Rheumatology, Hartford Hospital, Hartford, CT

    Background/Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a rare syndrome of excessive immune activation associated with high mortality. Early diagnosis and treatment can reduce mortality among these patients.…
  • « Previous Page
  • 1
  • …
  • 1676
  • 1677
  • 1678
  • 1679
  • 1680
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology